SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-20-003111
Filing Date
2020-01-10
Accepted
2020-01-10 17:21:17
Documents
17
Period of Report
2020-01-10
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm201779d1_8k.htm 8-K 23584
2 EXHIBIT 99.1 tm201779d1_ex99-1.htm EX-99.1 18162
3 GRAPHIC image_001.jpg GRAPHIC 44185
4 GRAPHIC image_002.jpg GRAPHIC 170140
5 GRAPHIC image_003.jpg GRAPHIC 109769
6 GRAPHIC image_004.jpg GRAPHIC 84454
7 GRAPHIC image_005.jpg GRAPHIC 90527
8 GRAPHIC image_006.jpg GRAPHIC 117892
9 GRAPHIC image_007.jpg GRAPHIC 77675
10 GRAPHIC image_008.jpg GRAPHIC 81734
11 GRAPHIC image_009.jpg GRAPHIC 76143
12 GRAPHIC image_010.jpg GRAPHIC 83613
13 GRAPHIC image_011.jpg GRAPHIC 83195
14 GRAPHIC image_012.jpg GRAPHIC 74698
15 GRAPHIC image_013.jpg GRAPHIC 77279
16 GRAPHIC image_014.jpg GRAPHIC 109762
17 GRAPHIC image_015.jpg GRAPHIC 44236
  Complete submission text file 0001104659-20-003111.txt   1870532
Mailing Address 16640 CHESTERFIELD GROVE ROAD SUITE 200 CHESTERFIELD MO 63005
Business Address BLOCK 10-1 BLANCHARDSTOWN CORPORATE PARK BALLYCOOLIN DUBLIN L2 15 636-449-1830
AVADEL PHARMACEUTICALS PLC (Filer) CIK: 0001012477 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37977 | Film No.: 20522005
SIC: 2834 Pharmaceutical Preparations